Steven Simmons
Interventional Pain Medicine · Fort Worth, TXNPI 1104815505
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,499 of the $9,738 with a category attached, or 66.7%. 49 manufacturers reported payments, led by Avanos Medical at 31.0% of the total. Reporting peaked in 2020 at $3,383 and has fallen 86.6% since, to $452 in 2025.
Across 317 payments — averaging $30.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avanos Medical$3K
- AbbVie$632
- Amgen$511
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$474
- Collegium Pharmaceutical, Inc.$472
- Angiodynamics, Inc.$372
- plus $4K from 43 others
Across 38 payments — averaging $178.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$7K
What the payments were for
- Speaking & faculty fees$2,98431%
- Travel & lodging$2342%
- Food & beverage$6,49967%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COOLIEF$2,984
- ClosureFast$181
- VenaCure 1470 Pro$177
- ReActiv8$138
- INTELLIS ADAPTIVESTIM$137
- Nimbus$110
How this compares
$9,738 in reported general payments places this provider in the 60th percentile of 287 interventional pain medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 13 | $5,773 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 105 | $2,774 |
| Oxycodone Hcl | 34 | $1,104 |
| Gabapentin | 29 | $427 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $399 |
| Tizanidine Hcl | 22 | $288 |
| Morphine Sulfate ErMorphine Sulfate | 13 | $238 |
| Methocarbamol | 20 | $230 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 12 | $176 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Fort Worth
- Timothy RatinoFort Worth$139K
- Robert MenziesFort Worth$85K
- Ashley ClassenFort Worth$43K
- Thomas RatinoFort Worth$20K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.1M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Brian BruelHouston$219K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.